Five selected causes of death accounted for 89.8 percent of fetal deaths in a reporting area of 41 states and the District of Columbia for 2018 to 2020, according to a report published online Oct. 19 in National Vital Statistics ...
Oct 20, 2022
0
16
(HealthDay)—In 2019, infant mortality reached a historic low in the United States, with a rate of 5.58 infant deaths per 1,000 live births, according to the Dec. 8 National Vital Statistics Reports, a publication from ...
Dec 8, 2021
0
12
Women with multiple sclerosis (MS) may not be at a higher risk of pregnancy complications like gestational diabetes, emergency cesarean section or stillbirth than women who do not have the disease, according to a study in ...
Feb 3, 2021
0
8
A recent paper published in The Economic Journal indicates that, in families with disabled children, the second born child is more adversely affected cognitively than the first-born child.
Aug 13, 2020
0
4
(HealthDay)—Five causes of death accounted for 89.5 percent of fetal deaths reported during 2015 to 2017, according to a report published April 15 in the U.S. Centers for Disease Control and Prevention National Vital Statistics ...
Apr 15, 2020
0
1
In so-called cloacal malformation (anal atresia), children are born without a rectal orifice or anus, or one that is malformed. This condition affects one in every 5,000 children. The congenital malformation can be corrected ...
Dec 5, 2019
0
2
(HealthDay)—Valproic acid and topiramate are confirmed teratogens, according to a study published online June 12 in Neurology.
Jun 13, 2019
0
0
(HealthDay)—It is important to discuss family planning and pregnancy proactively in women of childbearing age who have multiple sclerosis (MS), according to a review published online Jan. 5 in Practical Neurology.
Jan 31, 2019
0
2
Ondansetron (Zofran) is commonly and increasingly prescribed during pregnancy to relieve nausea. In 2014, an estimated 22 percent of pregnant women in the U.S. had used the drug at some point during their pregnancy. Despite ...
Dec 18, 2018
0
15
(HealthDay)—Maternal use of β-blockers in the first trimester of pregnancy is not associated with a large increase in the risk for overall or cardiac congenital malformations, according to a study published online Oct. ...
Oct 16, 2018
0
0
